Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
Clinical trial NCT03315104 · COMPLETED
Trial details
- NCT number
- NCT03315104
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-17
- Primary completion
- 2019-06-17
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.